Alzheimer Disease LMT-01-01-22
This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.
Research topics
Related studies
View all studiesAlzheimer's National Registry for Treatment and Diagnostics (ALZ-NET)
- Research study
Alzheimers/Cognitive Impairment NVI-039 AD
Proof of Concept of the Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment due to Alzheimer’s Disease
- Research study
Amyotrophic Lateral Sclerosis (ALS) CAPTURE
Clinical Procedures to Support Research in ALS (CAPTURE-ALS)
- Research study
Chronic Inflammatory Demyelinating Polyneuropathy Registry VRCIDP 5166-Vitaccess-CIDP-01
Vitaccess Real CIDP Registry: A Prospective International Observational Patient Registry in Chronic Inflammatory Demyelinating Polyneuropathy Linking Clinical and Patient-Reported Data 5166-Vitaccess-CIDP-01
- Research study
Parkinson's Disease Personalized Care Application iPD
Pilot study for Digital and Personalized care for Parkinson’s disease using Apple HealthKit (iPD study)